CRISPR Therapeutics $2.4 Billion Cash: Why the Stock Slump Persists
CRISPR Therapeutics wields a rare card: a cash-rich balance sheet and an approved gene therapy. But the stock refuses...
Knowing which debts to pay off first is crucial for effective financial management. Explore the best approaches to prioritize your repayments.
25,509 articlesCRISPR Therapeutics wields a rare card: a cash-rich balance sheet and an approved gene therapy. But the stock refuses...
A 69-year-old worker and a 67-year-old retiree face a pivotal retirement choice: keep funding a traditional IRA or pi...
Investors are backing a new space economy led by SpaceX, with launch costs cratering and Starship on the horizon. Ind...
A 58-year-old professional faces mounting debt and a lack of retirement savings as he plans a daughter's wedding. Exp...
AI sparks a data deluge, and storage stocks ride the wave. This guide breaks down how this storage stock more opportu...
A staggering, six-sigma-type move in tech stocks grabbed headlines. This article breaks down what happened, why it’s ...
A leading market technician says the baton in leadership is shifting from mega-cap tech to cyclical sectors, with thr...
Insilico Medicine and SK Biopharmaceuticals unveiled a milestone collaboration worth up to $2.5 billion to develop ne...
Bitcoin trades in a tight corridor near the mid-$60k range, defying a clear bullish breakout as ETF flows wane and Fe...
A 69-year-old widow faces a six-figure tax bill after considering rolling her late husband’s traditional IRA into her...
As excitement around Tesla’s humanoid robot mounts, a robotics ETF provides diversified exposure to the broader autom...
A high-stakes car-buying scam left a borrower on the hook for $22,000 after funds were wired to a fake dealer. This g...